Alembic Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: April 17, 2025, 10:54 am

Market Cap	2,671 Cr.
Current Price	104
High / Low	169/85.3
Stock P/E	8.49
Book Value	87.5
Dividend Yield	2.32 %
ROCE	4.81 %
ROE	12.6 %
Face Value	2.00
PEG Ratio	-4.93

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Alembic Ltd

Competitors of Alembic Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Hampton Sky Realty Ltd	717 Cr.	26.1	38.3/20.5	30.0	5.74	0.00 %	15.7 %	10.6 %	1.00
Grovy India Ltd	70.7 Cr.	53.0	98.2/22.6	43.4	13.9	0.05 %	5.79 %	5.27 %	10.0
Gothi Plascon (India) Ltd	52.3 Cr.	51.3	53.6/32.2	34.4	12.4	3.90 %	17.8 %	12.9 %	10.0
Generic Engineering Construction & Projects Ltd	180 Cr.	31.7	71.0/22.0	17.5	48.5	0.00 %	6.61 %	4.33 %	5.00
Garnet Construction Ltd	36.2 Cr.	26.0	57.2/21.6	6.80	73.3	0.00 %	4.51 %	3.13 %	10.0
Industry Average	17,272.96 Cr	431.00		48.68	132.01	0.56%	10.29%	8.69%	6.13

All Competitor Stocks of Alembic Ltd

Quarterly Result

Metric	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	19	18	22	37	31	37	37	32	39	49	51	53	58
Expenses	16	15	17	26	20	24	26	22	28	25	30	33	32
Operating Profit	4	3	5	11	10	13	11	10	12	24	20	20	26
OPM %	19%	16%	25%	30%	34%	36%	30%	31%	30%	49%	40%	37%	46%
Other Income	2	4	1	59	2	-9	3	48	2	2	2	66	4
Interest	0	0	0	0	0	0	0	0	0	0	0	1	1
Depreciation	1	1	2	2	2	2	2	2	3	1	2	3	3
Profit before tax	4	6	4	68	11	3	12	56	11	24	19	82	27
Tax %	4%	20%	11%	10%	2%	-55%	14%	8%	9%	12%	10%	6%	5%
Net Profit	52	1	-19	115	46	48	44	91	61	72	56	121	65
EPS in Rs	2.02	0.04	-0.72	4.49	1.78	1.88	1.73	3.53	2.39	2.81	2.17	4.71	2.55

Last Updated: February 28, 2025, 8:42 pm

Below is a detailed analysis of the quarterly data for Alembic Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is 58.00 Cr.. The value appears strong and on an upward trend. It has increased from 53.00 Cr. (Sep 2024) to 58.00 Cr., marking an increase of 5.00 Cr..
For Expenses, as of Dec 2024, the value is 32.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 33.00 Cr. (Sep 2024) to 32.00 Cr., marking a decrease of 1.00 Cr..
For Operating Profit, as of Dec 2024, the value is 26.00 Cr.. The value appears strong and on an upward trend. It has increased from 20.00 Cr. (Sep 2024) to 26.00 Cr., marking an increase of 6.00 Cr..
For OPM %, as of Dec 2024, the value is 46.00%. The value appears strong and on an upward trend. It has increased from 37.00% (Sep 2024) to 46.00%, marking an increase of 9.00%.
For Other Income, as of Dec 2024, the value is 4.00 Cr.. The value appears to be declining and may need further review. It has decreased from 66.00 Cr. (Sep 2024) to 4.00 Cr., marking a decrease of 62.00 Cr..
For Interest, as of Dec 2024, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 1.00 Cr..
For Depreciation, as of Dec 2024, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 3.00 Cr..
For Profit before tax, as of Dec 2024, the value is 27.00 Cr.. The value appears to be declining and may need further review. It has decreased from 82.00 Cr. (Sep 2024) to 27.00 Cr., marking a decrease of 55.00 Cr..
For Tax %, as of Dec 2024, the value is 5.00%. The value appears to be improving (decreasing) as expected. It has decreased from 6.00% (Sep 2024) to 5.00%, marking a decrease of 1.00%.
For Net Profit, as of Dec 2024, the value is 65.00 Cr.. The value appears to be declining and may need further review. It has decreased from 121.00 Cr. (Sep 2024) to 65.00 Cr., marking a decrease of 56.00 Cr..
For EPS in Rs, as of Dec 2024, the value is 2.55. The value appears to be declining and may need further review. It has decreased from 4.71 (Sep 2024) to 2.55, marking a decrease of 2.16.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 7, 2025, 9:20 pm

Metric	Mar 2009	Mar 2010	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	1,099	1,121	144	134	147	125	124	74	74	78	127	157	211
Expenses	1,016	1,018	134	128	140	114	106	71	62	64	87	101	120
Operating Profit	83	103	10	6	7	11	18	3	11	14	40	57	91
OPM %	8%	9%	7%	5%	5%	9%	15%	4%	15%	18%	32%	36%	43%
Other Income	7	16	21	25	25	37	29	93	10	89	54	55	74
Interest	42	32	1	0	0	0	0	0	0	0	0	1	2
Depreciation	38	43	6	6	5	4	3	3	4	5	7	8	9
Profit before tax	9	44	23	25	27	44	45	93	17	98	87	103	153
Tax %	-19%	10%	-3%	2%	-3%	5%	8%	0%	19%	12%	7%	10%
Net Profit	11	40	107	235	145	163	213	329	343	222	191	269	314
EPS in Rs	0.39	1.48	3.99	8.78	5.45	6.10	8.30	12.82	13.35	8.65	7.42	10.46	12.24
Dividend Payout %	51%	17%	4%	2%	4%	3%	2%	5%	2%	21%	30%	23%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2009-2010	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	263.64%	119.63%	-38.30%	12.41%	30.67%	54.46%	4.26%	-35.28%	-13.96%	40.84%
Change in YoY Net Profit Growth (%)	0.00%	-144.01%	-157.92%	50.71%	18.26%	23.79%	-50.20%	-39.53%	21.31%	54.80%

Alembic Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 10 years from 2009-2010 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	%
5 Years:	5%
3 Years:	29%
TTM:	45%

Compounded Profit Growth
10 Years:	%
5 Years:	5%
3 Years:	-8%
TTM:	23%

Stock Price CAGR
10 Years:	13%
5 Years:	18%
3 Years:	9%
1 Year:	14%

Return on Equity
10 Years:	%
5 Years:	14%
3 Years:	10%
Last Year:	13%

Last Updated: Unknown

Balance Sheet

Last Updated: November 15, 2024, 1:44 am

Month	Mar 2009	Mar 2010	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	27	27	53	53	53	53	51	51	51	51	51	51	51
Reserves	304	311	474	750	858	1,032	1,157	1,367	2,246	2,445	2,027	2,134	2,195
Borrowings	475	408	0	9	0	0	0	0	0	0	0	9	16
Other Liabilities	209	251	91	64	81	73	57	53	112	135	127	134	178
Total Liabilities	1,015	997	619	875	992	1,159	1,266	1,471	2,409	2,632	2,205	2,329	2,441
Fixed Assets	405	393	169	146	171	179	209	225	265	297	321	369	385
CWIP	7	4	2	0	0	0	0	3	6	0	0	1	0
Investments	8	8	299	605	732	913	1,001	1,133	2,047	2,208	1,754	1,786	1,850
Other Assets	595	591	149	124	89	67	55	110	91	127	130	173	206
Total Assets	1,015	997	619	875	992	1,159	1,266	1,471	2,409	2,632	2,205	2,329	2,441

Below is a detailed analysis of the balance sheet data for Alembic Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is ₹51.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 51.00 Cr..
For Reserves, as of Sep 2024, the value is ₹2,195.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,134.00 Cr. (Mar 2024) to ₹2,195.00 Cr., marking an increase of 61.00 Cr..
For Borrowings, as of Sep 2024, the value is ₹16.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 9.00 Cr. (Mar 2024) to ₹16.00 Cr., marking an increase of 7.00 Cr..
For Other Liabilities, as of Sep 2024, the value is ₹178.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 134.00 Cr. (Mar 2024) to ₹178.00 Cr., marking an increase of 44.00 Cr..
For Total Liabilities, as of Sep 2024, the value is ₹2,441.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,329.00 Cr. (Mar 2024) to ₹2,441.00 Cr., marking an increase of 112.00 Cr..
For Fixed Assets, as of Sep 2024, the value is ₹385.00 Cr.. The value appears strong and on an upward trend. It has increased from 369.00 Cr. (Mar 2024) to ₹385.00 Cr., marking an increase of 16.00 Cr..
For CWIP, as of Sep 2024, the value is ₹0.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Mar 2024) to ₹0.00 Cr., marking a decrease of 1.00 Cr..
For Investments, as of Sep 2024, the value is ₹1,850.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,786.00 Cr. (Mar 2024) to ₹1,850.00 Cr., marking an increase of 64.00 Cr..
For Other Assets, as of Sep 2024, the value is ₹206.00 Cr.. The value appears strong and on an upward trend. It has increased from 173.00 Cr. (Mar 2024) to ₹206.00 Cr., marking an increase of 33.00 Cr..
For Total Assets, as of Sep 2024, the value is ₹2,441.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,329.00 Cr. (Mar 2024) to ₹2,441.00 Cr., marking an increase of 112.00 Cr..

Notably, the Reserves (2,195.00 Cr.) exceed the Borrowings (16.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2009	Mar 2010	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	123	149	22	10	52	24	22	7	-2	-18	39	23
Cash from Investing Activity +	-56	-24	5	-5	-47	-22	68	57	-35	19	7	26
Cash from Financing Activity +	-70	-118	-25	-5	-5	-3	-89	-6	-15	-6	-46	-48
Net Cash Flow	-2	7	2	-0	-0	-1	1	57	-52	-5	-0	0

Free Cash Flow

Month	Mar 2009	Mar 2010	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	-392.00	-305.00	10.00	-3.00	7.00	11.00	18.00	3.00	11.00	14.00	40.00	48.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2009	Mar 2010	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	71	63	122	76	54	74	40	44	69	71	67	46
Inventory Days	158	158	880	659	438	247	289	411	2,112	2,885		3,694
Days Payable	112	128	200	144	128	125	202	151	693	640		1,237
Cash Conversion Cycle	117	93	801	591	364	195	126	305	1,488	2,316	67	2,502
Working Capital Days	125	108	235	172	39	20	13	22	98	223	118	81
ROCE %	7%	10%		4%	4%	4%	4%	7%	1%	4%	4%	5%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
Promoters	70.88%	70.88%	70.88%	70.88%	70.88%	70.88%	70.88%	70.88%	70.88%	70.88%	70.88%	70.88%
FIIs	1.23%	1.19%	1.12%	1.08%	0.83%	0.82%	0.70%	0.72%	0.85%	0.89%	1.07%	1.42%
DIIs	4.89%	5.17%	4.69%	4.29%	4.12%	3.94%	3.94%	3.93%	3.40%	0.04%	0.04%	0.04%
Public	23.00%	22.76%	23.31%	23.75%	24.16%	24.34%	24.48%	24.46%	24.87%	28.17%	28.02%	27.66%
No. of Shareholders	80,561	78,381	80,135	83,006	83,612	83,630	82,339	81,732	82,947	94,012	99,130	98,478

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
SBI Small Cap Fund	10,000,000	0.39	81.35	10,000,000	2025-04-12	0%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	2.00	2.00	2.00	2.00	2.00
Basic EPS (Rs.)	10.46	7.42	8.65	13.35	12.82
Diluted EPS (Rs.)	10.46	7.42	8.65	13.35	12.82
Cash EPS (Rs.)	3.92	3.40	3.55	0.69	3.75
Book Value[Excl.RevalReserv]/Share (Rs.)	85.11	80.93	97.23	89.45	55.22
Book Value[Incl.RevalReserv]/Share (Rs.)	85.11	80.93	97.23	89.45	55.22
Revenue From Operations / Share (Rs.)	6.13	4.96	3.05	2.86	2.88
PBDIT / Share (Rs.)	4.35	4.07	4.02	0.83	3.77
PBIT / Share (Rs.)	4.04	3.81	3.83	0.67	3.64
PBT / Share (Rs.)	4.00	3.38	3.81	0.66	3.63
Net Profit / Share (Rs.)	3.62	3.14	3.36	0.53	3.62
NP After MI And SOA / Share (Rs.)	10.46	7.42	8.65	13.35	12.82
PBDIT Margin (%)	70.88	82.20	131.82	29.03	130.77
PBIT Margin (%)	65.90	76.91	125.60	23.67	126.41
PBT Margin (%)	65.20	68.21	125.10	23.18	126.02
Net Profit Margin (%)	58.96	63.35	110.19	18.82	125.84
NP After MI And SOA Margin (%)	170.56	149.83	283.89	466.35	445.19
Return on Networth / Equity (%)	12.29	9.17	8.89	14.92	23.20
Return on Capital Employeed (%)	4.63	4.61	3.83	0.74	6.55
Return On Assets (%)	11.53	8.64	8.43	14.23	22.37
Asset Turnover Ratio (%)	0.06	0.05	0.04	0.06	0.08
Current Ratio (X)	1.52	2.05	2.12	1.72	3.56
Quick Ratio (X)	0.49	0.99	0.83	0.80	2.78
Inventory Turnover Ratio (X)	0.09	0.07	0.12	0.26	0.69
Dividend Payout Ratio (NP) (%)	21.03	24.24	2.31	4.49	1.88
Dividend Payout Ratio (CP) (%)	20.43	23.41	2.26	4.44	1.86
Earning Retention Ratio (%)	78.97	75.76	97.69	95.51	98.12
Cash Earning Retention Ratio (%)	79.57	76.59	97.74	95.56	98.14
Interest Coverage Ratio (X)	100.70	224.79	265.00	58.96	335.70
Interest Coverage Ratio (Post Tax) (X)	84.77	197.06	222.52	39.24	324.04
Enterprise Value (Cr.)	2154.92	1520.56	1855.97	2634.71	857.86
EV / Net Operating Revenue (X)	13.68	11.95	23.73	35.84	11.60
EV / EBITDA (X)	19.30	14.54	18.00	123.44	8.87
MarketCap / Net Operating Revenue (X)	13.64	11.97	23.75	35.92	12.40
Retention Ratios (%)	78.96	75.75	97.68	95.50	98.11
Price / BV (X)	0.98	0.73	0.74	1.15	0.64
Price / Net Operating Revenue (X)	13.64	11.97	23.75	35.93	12.40
EarningsYield	0.12	0.12	0.11	0.12	0.35

After reviewing the key financial ratios for Alembic Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
For Basic EPS (Rs.), as of Mar 24, the value is 10.46. This value is within the healthy range. It has increased from 7.42 (Mar 23) to 10.46, marking an increase of 3.04.
For Diluted EPS (Rs.), as of Mar 24, the value is 10.46. This value is within the healthy range. It has increased from 7.42 (Mar 23) to 10.46, marking an increase of 3.04.
For Cash EPS (Rs.), as of Mar 24, the value is 3.92. This value is within the healthy range. It has increased from 3.40 (Mar 23) to 3.92, marking an increase of 0.52.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 85.11. It has increased from 80.93 (Mar 23) to 85.11, marking an increase of 4.18.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 85.11. It has increased from 80.93 (Mar 23) to 85.11, marking an increase of 4.18.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 6.13. It has increased from 4.96 (Mar 23) to 6.13, marking an increase of 1.17.
For PBDIT / Share (Rs.), as of Mar 24, the value is 4.35. This value is within the healthy range. It has increased from 4.07 (Mar 23) to 4.35, marking an increase of 0.28.
For PBIT / Share (Rs.), as of Mar 24, the value is 4.04. This value is within the healthy range. It has increased from 3.81 (Mar 23) to 4.04, marking an increase of 0.23.
For PBT / Share (Rs.), as of Mar 24, the value is 4.00. This value is within the healthy range. It has increased from 3.38 (Mar 23) to 4.00, marking an increase of 0.62.
For Net Profit / Share (Rs.), as of Mar 24, the value is 3.62. This value is within the healthy range. It has increased from 3.14 (Mar 23) to 3.62, marking an increase of 0.48.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 10.46. This value is within the healthy range. It has increased from 7.42 (Mar 23) to 10.46, marking an increase of 3.04.
For PBDIT Margin (%), as of Mar 24, the value is 70.88. This value is within the healthy range. It has decreased from 82.20 (Mar 23) to 70.88, marking a decrease of 11.32.
For PBIT Margin (%), as of Mar 24, the value is 65.90. This value exceeds the healthy maximum of 20. It has decreased from 76.91 (Mar 23) to 65.90, marking a decrease of 11.01.
For PBT Margin (%), as of Mar 24, the value is 65.20. This value is within the healthy range. It has decreased from 68.21 (Mar 23) to 65.20, marking a decrease of 3.01.
For Net Profit Margin (%), as of Mar 24, the value is 58.96. This value exceeds the healthy maximum of 10. It has decreased from 63.35 (Mar 23) to 58.96, marking a decrease of 4.39.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 170.56. This value exceeds the healthy maximum of 20. It has increased from 149.83 (Mar 23) to 170.56, marking an increase of 20.73.
For Return on Networth / Equity (%), as of Mar 24, the value is 12.29. This value is below the healthy minimum of 15. It has increased from 9.17 (Mar 23) to 12.29, marking an increase of 3.12.
For Return on Capital Employeed (%), as of Mar 24, the value is 4.63. This value is below the healthy minimum of 10. It has increased from 4.61 (Mar 23) to 4.63, marking an increase of 0.02.
For Return On Assets (%), as of Mar 24, the value is 11.53. This value is within the healthy range. It has increased from 8.64 (Mar 23) to 11.53, marking an increase of 2.89.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.06. It has increased from 0.05 (Mar 23) to 0.06, marking an increase of 0.01.
For Current Ratio (X), as of Mar 24, the value is 1.52. This value is within the healthy range. It has decreased from 2.05 (Mar 23) to 1.52, marking a decrease of 0.53.
For Quick Ratio (X), as of Mar 24, the value is 0.49. This value is below the healthy minimum of 1. It has decreased from 0.99 (Mar 23) to 0.49, marking a decrease of 0.50.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 0.09. This value is below the healthy minimum of 4. It has increased from 0.07 (Mar 23) to 0.09, marking an increase of 0.02.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 21.03. This value is within the healthy range. It has decreased from 24.24 (Mar 23) to 21.03, marking a decrease of 3.21.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 20.43. This value is within the healthy range. It has decreased from 23.41 (Mar 23) to 20.43, marking a decrease of 2.98.
For Earning Retention Ratio (%), as of Mar 24, the value is 78.97. This value exceeds the healthy maximum of 70. It has increased from 75.76 (Mar 23) to 78.97, marking an increase of 3.21.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 79.57. This value exceeds the healthy maximum of 70. It has increased from 76.59 (Mar 23) to 79.57, marking an increase of 2.98.
For Interest Coverage Ratio (X), as of Mar 24, the value is 100.70. This value is within the healthy range. It has decreased from 224.79 (Mar 23) to 100.70, marking a decrease of 124.09.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 84.77. This value is within the healthy range. It has decreased from 197.06 (Mar 23) to 84.77, marking a decrease of 112.29.
For Enterprise Value (Cr.), as of Mar 24, the value is 2,154.92. It has increased from 1,520.56 (Mar 23) to 2,154.92, marking an increase of 634.36.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 13.68. This value exceeds the healthy maximum of 3. It has increased from 11.95 (Mar 23) to 13.68, marking an increase of 1.73.
For EV / EBITDA (X), as of Mar 24, the value is 19.30. This value exceeds the healthy maximum of 15. It has increased from 14.54 (Mar 23) to 19.30, marking an increase of 4.76.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 13.64. This value exceeds the healthy maximum of 3. It has increased from 11.97 (Mar 23) to 13.64, marking an increase of 1.67.
For Retention Ratios (%), as of Mar 24, the value is 78.96. This value exceeds the healthy maximum of 70. It has increased from 75.75 (Mar 23) to 78.96, marking an increase of 3.21.
For Price / BV (X), as of Mar 24, the value is 0.98. This value is below the healthy minimum of 1. It has increased from 0.73 (Mar 23) to 0.98, marking an increase of 0.25.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 13.64. This value exceeds the healthy maximum of 3. It has increased from 11.97 (Mar 23) to 13.64, marking an increase of 1.67.
For EarningsYield, as of Mar 24, the value is 0.12. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.12.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Alembic Ltd as of April 17, 2025 is: 76.62

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of April 17, 2025, Alembic Ltd is Overvalued by 26.33% compared to the current share price 104.00

Intrinsic Value of Alembic Ltd as of April 17, 2025 is: 75.30

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of April 17, 2025, Alembic Ltd is Overvalued by 27.60% compared to the current share price 104.00

Last 5 Year EPS CAGR: -1.72%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The company has higher reserves (1,330.77 cr) compared to borrowings (70.54 cr), indicating strong financial stability. The company has shown consistent growth in sales (107.46 cr) and profit (59.08 cr) over the years.	The stock has a low average ROCE of 4.50%, which may not be favorable. The stock has a high average Working Capital Days of 104.50, which may not be favorable. The stock has a high average Cash Conversion Cycle of 222.00, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Alembic Ltd:
1. Net Profit Margin: 58.96%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 4.63% (Industry Average ROCE: 9.97%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 12.29% (Industry Average ROE: 8.15%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 84.77
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 0.49
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 8.49 (Industry average Stock P/E: 42.6)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Alembic Ltd. is a Public Limited Listed company incorporated on 30/07/1907 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L26100GJ1907PLC000033 and registration number is 000033. Currently Company is involved in the business activities of Real estate activities with own or leased property. Company's Total Operating Revenue is Rs. 152.25 Cr. and Equity Capital is Rs. 51.36 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
Realty	Alembic Road, Vadodra Gujarat 390003	alembic.investors@alembic.co.in http://www.alembiclimited.com

Management
Name	Position Held
Mr. Chirayu Amin	Chairman
Mrs. Malika Amin	Managing Director & CEO
Mr. Udit Amin	Director
Mr. Abhijit Joshi	Director
Mrs. Rati Desai	Independent Director
Mr. Sameer Khera	Independent Director
Mr. Mayank Amin	Independent Director
Dr. Girish Hirode	Independent Director

FAQ

What is the intrinsic value of Alembic Ltd?

Alembic Ltd's intrinsic value (as of 17 April 2025) is ₹76.62 — 26.33% lower the current market price of 104.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 2,671 Cr. market cap, FY2025-2026 high/low of ₹169/85.3, reserves of 2,195 Cr, and liabilities of 2,441 Cr.

What is the Market Cap of Alembic Ltd?

The Market Cap of Alembic Ltd is 2,671 Cr..

What is the current Stock Price of Alembic Ltd as on 17 April 2025?

The current stock price of Alembic Ltd as on 17 April 2025 is 104.

What is the High / Low of Alembic Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of Alembic Ltd stocks is ₹169/85.3.

What is the Stock P/E of Alembic Ltd?

The Stock P/E of Alembic Ltd is 8.49.

What is the Book Value of Alembic Ltd?

The Book Value of Alembic Ltd is 87.5.

What is the Dividend Yield of Alembic Ltd?

The Dividend Yield of Alembic Ltd is 2.32 %.

What is the ROCE of Alembic Ltd?

The ROCE of Alembic Ltd is 4.81 %.

What is the ROE of Alembic Ltd?

The ROE of Alembic Ltd is 12.6 %.

What is the Face Value of Alembic Ltd?

The Face Value of Alembic Ltd is 2.00.